readthroughSign in
Oct 19, 2026People

Tempest Therapeutics appoints John W. Frederick to board of directors

The clinical-stage CAR-T company named the former Skillsoft CFO as a Class III director effective October 13, 2026.

Tempest Therapeutics, Inc. (Nasdaq: TPST) said on October 14, 2026 that it had appointed John W. Frederick to its board of directors. According to the company's 8-K filing, effective October 13, 2026, the board appointed Frederick as a Class III director.1 He will serve until the company's 2027 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal.1

Frederick, age 62, is described in the filing as a retired senior financial and operating executive with more than three decades of leadership experience across public, private equity-backed and venture-backed companies, principally in technology and technology-enabled businesses.1 From May 2025 to September 2026, he served as Chief Financial Officer of Skillsoft Corp. (NYSE: SKIL), and previously, beginning in August 2024, he served as Skillsoft's Chief Transformation Officer, a position in which he oversaw Skillsoft's business planning.1 From September 2021 to February 2024, he held strategic leadership positions at Indigo Ag, Inc., an agriculture technology company, including Global Head of Carbon Commercial Operations and Chief Financial Officer.1 He also held senior positions at a predecessor Skillsoft entity, serving as Chief Administrative Officer from November 2018 to June 2021 and simultaneously as Chief Executive Officer of SumTotal Systems LLC, a former subsidiary of that entity, from September 2019 to June 2021.1

As compensation, Frederick will receive an initial option award to purchase 25,000 shares of the company's common stock under Tempest's 2023 Equity Incentive Plan, under the terms of its Non-Employee Director Compensation Policy.1 The filing states there are no arrangements or understandings between Frederick and any other person pursuant to which he was appointed, no family relationships with the company's directors or executive officers, and no related-party transactions requiring disclosure.1

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.